Criticisms of the DSM-IV: Subjectivity, Cultural Bias, and Comorbidity

The DSM-IV (1994, TR 2000) faced significant criticism, many addressed in DSM-5 (2013).

Major Criticisms

1. Over-reliance on Subjective Criteria: Symptom thresholds based on clinician judgment → low inter-rater reliability for some disorders.
2. Cultural Insensitivity: Criteria normed on Western populations; cultural idioms of distress ignored → misdiagnosis/underdiagnosis in minorities. Cultural Formulation Outline added but underused.
3. High Comorbidity: Overlapping criteria (e.g., GAD + MDD) → artificial fragmentation, diagnostic confusion, polypharmacy.
4. Limited Validity/Reliability: Categorical model vs. dimensional reality. Threshold effects (subthreshold = no diagnosis). Field trials showed variable kappa.
5. Stigmatization: Labels → discrimination, self-stigma, insurance barriers.
6. Medicalization of Normal Experience: Grief, shyness, childhood exuberance pathologized.
7. Pharmaceutical Influence: Panel ties to industry; diagnostic expansion = market expansion.

DSM-5 Improvements

Dimensional assessments (WHODAS, severity specifiers), cultural formulation interview, combined substance use disorders, ASD spectrum, removed bereavement exclusion, RDoC alignment.

Critique continues; ICD-11 offers alternative framework.